Program
In-person AND virtual! – We are pioneering a new conference format that will connect in-person and virtual audiences to create a unique experience. Matching the innovation that comes through our members’ work, ISPOR is pushing the boundaries
of innovation to design an event that works in today’s quickly changing environment.
In-person registration included the full virtual experience, and virtual-only attendees will be able to tune into live in-person sessions and/or
watch captured in-person sessions on-demand in addition to having a variety of virtual-only sessions to attend.
A Descriptive Study on Hospital-Related Coronavirus Disease 2019 (HRCOVID-19) Among Chronic Kidney Disease Patients during the Pandemic at a Tertiary Center in the Philippines
Speaker(s)
Cruz IMD1, Mendoza M2
1National Kidney and Transplant Institute, Quezon City, Metro Manila, Philippines, 2National Kidney and Transplant Institute, Quezon City, Philippines
Presentation Documents
OBJECTIVES:
The study aimed to determine the incidence of hospital-related COVID-19 (HrCOVID-19) among chronic kidney disease (CKD) patients in a specialty medical center in the PhilippinesMETHODS:
A retrospective descriptive cross-sectional design with record review was done. The hospital’s list of confirmed COVID-19 was used to determine cases who developed signs and symptoms more than 14 days of hospital stay. Outcome categories, either discharged alive or mortality, were also identified.RESULTS:
Twenty-nine patients were included, predominantly males (55%) with mean age of 47 ± 14 years. Length of hospital stay to HrCOVID-19 confirmation was 24 days. An overall incidence rate of 1.26% (95% CI: 0.84-1.80) was seen, and peaked at 2.35% (95% CI: 1.13 – 4.28) in June 2020. Overall mortality rate was 45%. CONCLUSION: Incidence of HrCOVID-19 among CKD patients was low but has high mortality rates. Active identification, containment and prevention of in-hospital transmissions to achieve zero cases is desirable.Code
EPH121
Topic
Epidemiology & Public Health
Disease
Respiratory-Related Disorders, Systemic Disorders/Conditions, Urinary/Kidney Disorders